EC Number   |
Inhibitors |
Structure |
|---|
    1.1.1.140 | 3-(5-((E)-[3,5-bis(methoxycarbonyl)phenyl]diazenyl)-2-hydroxyphenyl)propanoic acid |
enzyme inhibition is accompanied by a decrease in total prostaglandin F2alpha |
   |
| 1.1.1.140 | 5-([5-(3-chlorophenyl)furan-2-yl]methyl)-1,3-thiazolidine-2,4-dione |
- |
|
| 1.1.1.140 | 5-phospho-D-arabinonate |
substrate analogue inhibitor, IC50: 0.048 mM |
|
| 1.1.1.140 | 5-phospho-D-arabinonohydroxamic acid |
substrate analogue inhibitor, IC50: 0.040 mM |
|
| 1.1.1.140 | CO32- |
- |
|
| 1.1.1.140 | D-mannose 6-phosphate |
potent inhibitor, IC50: 0.0075 mM |
|
| 1.1.1.140 | diethyl dicarbonate |
100% inactivation |
|
| 1.1.1.140 | disodium 4-(5-[(Z)-(4-oxido-2-oxo-1,3-thiazol-5(2H)-ylidene)methyl]furan-2-yl)benzoate |
reduces deactivated prostaglandin F2alpha metabolite production in outer root sheath keratinocyte supernatant |
|
| 1.1.1.140 | ethyl 3-(5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]furan-2-yl)benzoate |
- |
|
| 1.1.1.140 | methyl 3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)propanoate |
- |
|
